Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Autolus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for AUTL.
You can purchase shares of Autolus Therapeutics (NASDAQ:AUTL) through any online brokerage.
Other companies in Autolus Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Precigen (NASDAQ:PGEN), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC) and Altimmune (NASDAQ:ALT).
Autolus Therapeutics has a consensus price target of $9.38.
The stock price for Autolus Therapeutics (NASDAQ: AUTL) is $1.48 last updated April 23, 2025 at 7:52 PM EDT.
There are no upcoming dividends for Autolus Therapeutics.
Autolus Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.
There is no upcoming split for Autolus Therapeutics.
Autolus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.